These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

433 related items for PubMed ID: 8135494

  • 21. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
    Happ B, Hynes NE, Groner B.
    Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
    [Abstract] [Full Text] [Related]

  • 22. [Detection of 8 oncogenes in squamous epithelial cancers of the head and neck].
    Jungehülsing M, Volling P.
    HNO; 1994 May; 42(5):280-7. PubMed ID: 8050916
    [Abstract] [Full Text] [Related]

  • 23. Oncogenes and antioncogenes in human breast carcinoma.
    Leslie KO, Howard P.
    Pathol Annu; 1992 May; 27 Pt 1():321-42. PubMed ID: 1346552
    [No Abstract] [Full Text] [Related]

  • 24. [Oncogenes, antioncogenes and carcinogenesis].
    Kopnin BP.
    Arkh Patol; 1990 May; 52(9):3-11. PubMed ID: 2270978
    [Abstract] [Full Text] [Related]

  • 25. [Oncogenes in squamous epithelial cancers in the area of the head and neck].
    Volling P, Jungehülsing M, Tesch H, Stennert E.
    Laryngol Rhinol Otol (Stuttg); 1988 Apr; 67(4):160-4. PubMed ID: 3386367
    [Abstract] [Full Text] [Related]

  • 26. Oncogenes and tumour suppressor genes in breast cancer.
    Eccles MR, Phipps RF.
    Br J Hosp Med; 1988 Apr; 50(9):529-36. PubMed ID: 7904528
    [Abstract] [Full Text] [Related]

  • 27. Oncogenes, onco-suppressors, carcinogenesis and oral cancer.
    Scully C.
    Br Dent J; 1992 Jul 25; 173(2):53-9. PubMed ID: 1386990
    [Abstract] [Full Text] [Related]

  • 28. Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells.
    Ivan M, Bond JA, Prat M, Comoglio PM, Wynford-Thomas D.
    Oncogene; 1997 May 22; 14(20):2417-23. PubMed ID: 9188856
    [Abstract] [Full Text] [Related]

  • 29. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun 22; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 30. The functions of oncogene products.
    Hunter T.
    Prog Clin Biol Res; 1989 Jun 22; 288():25-34. PubMed ID: 2541449
    [No Abstract] [Full Text] [Related]

  • 31. Viruses, oncogenes, and cancer.
    Rhim JS.
    Cancer Detect Prev; 1988 Jun 22; 11(3-6):139-49. PubMed ID: 3292041
    [Abstract] [Full Text] [Related]

  • 32. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ, Ohshiro K, Rayala SK, El-Naggar AK, Kumar R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4291-9. PubMed ID: 17634559
    [Abstract] [Full Text] [Related]

  • 33. Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas.
    Chung CH, Ely K, McGavran L, Varella-Garcia M, Parker J, Parker N, Jarrett C, Carter J, Murphy BA, Netterville J, Burkey BB, Sinard R, Cmelak A, Levy S, Yarbrough WG, Slebos RJ, Hirsch FR.
    J Clin Oncol; 2006 Sep 01; 24(25):4170-6. PubMed ID: 16943533
    [Abstract] [Full Text] [Related]

  • 34. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA, Smith LJ, Fontaine MP, Kay HD, Mountjoy CP, Pirruccello SJ.
    Ann Thorac Surg; 1995 Dec 01; 60(6):1583-91. PubMed ID: 8787447
    [Abstract] [Full Text] [Related]

  • 35. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB, Murty VV, Pratap M, Sodhani P, Chaganti RS.
    Cancer Res; 1994 Feb 01; 54(3):637-9. PubMed ID: 7905784
    [Abstract] [Full Text] [Related]

  • 36. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993 Feb 01; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 37. [2000 Standards, Options and Recommendations for prognostic value of oncogenes and tumor suppressor genes in non small cell lung cancer].
    Bréchot JM, Molina T, Theobald S, Depierre A, Lagrange JL, Astoul P, Baldeyrou P, Bardet E, Bazelly B, Breton JL, Douillard JY, Grivaux M, Jacoulet P, Khalil A, Lemarié E, Martinet Y, Massard G, Milleron B, Moro-Sibilot D, Paesmans M, Pujol JL, Quoix AE, Ranfaing E, Rivière A, Sancho-Garnier H, Souquet PJ, Spaeth D, Stcebner-Delbarre A, FNCLCC, CRLCC.
    Bull Cancer; 2002 Oct 01; 89(10):857-67. PubMed ID: 12441277
    [Abstract] [Full Text] [Related]

  • 38. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
    Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C.
    Cancer Res; 2003 Mar 15; 63(6):1179-82. PubMed ID: 12649172
    [Abstract] [Full Text] [Related]

  • 39. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types.
    Prins J, De Vries EG, Mulder NH.
    Anticancer Res; 1993 Mar 15; 13(5A):1373-85. PubMed ID: 8239508
    [Abstract] [Full Text] [Related]

  • 40. Molecular correlates of cytogenetic abnormalities in human cancer cells: implications for oncogene activation.
    Brodeur GM.
    Prog Hematol; 1986 Mar 15; 14():229-56. PubMed ID: 3003796
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.